New imaging technique aims to sharpen prostate cancer radiation
NCT ID NCT07393867
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is for men with intermediate- or high-risk prostate cancer who will receive hormone therapy and radiation. Researchers want to see if using a special PET scan (PSMA PET) during hormone therapy can help doctors better target remaining cancer with radiation while avoiding healthy tissue. Participants will get standard treatments plus three imaging scans over six months. The goal is to make radiation more precise and reduce side effects in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PSMA PET/CT imaging and androgen deprivation therapy (ADT) with or without bicalutamide
What this could lead to
If successful, this could lead to more precise radiation treatment for prostate cancer, potentially reducing side effects while maintaining effectiveness.
What could go wrong
This is a small, early-phase study with only 23 participants, so results may not apply to all patients. The imaging technique may not improve outcomes as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02115, United States
-
Dana Farber Cancer Institute
NOT_YET_RECRUITINGBoston, Massachusetts, 02115, United States
-
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
RECRUITINGMilford, Massachusetts, 01757, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital
RECRUITINGWeymouth, Massachusetts, 02190, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••